Jules A Cohen MD
Associate Professor of Clinical Medicine, Stony Brook University
1 Lauterbur DriveStony Brook, NY 11794
Overview of Dr. Cohen
Dr. Jules Cohen is an oncologist based in Stony Brook, NY, who completed their medical education at Weill Cornell Medicine in 2001, followed by a residency in Internal Medicine and a fellowship in Hematology and Medical Oncology at New York Presbyterian Hospital (Cornell Campus). Dr. Cohen has authored several publications on breast cancer and imaging techniques and has served as a principal investigator in clinical trials focusing on HER2/Neu positive breast cancer treatments. They have received multiple CMS Meaningful Use Stage 1 certifications from Cerner Corporation.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2007 - 2010- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2005
Weill Cornell MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2002 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2016
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects Start of enrollment: 2022 Aug 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Biologics and Drug-Induced Immunogenicity: A Case Report of Acquired Hemophilia A Presenting After Immunotherapy.Kevin A Murgas, Sundus Nasim, Stephen Poos, Jules A Cohen, Anna Andrzejczyk
Clinical Case Reports. 2026-05-01 - Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study.Julie Anne L Gemmill, Patricia Thompson, Rebecca Batiste, Caterina Vacchi-Suzzi, Christina Preece
Breast Cancer Research and Treatment. 2025-07-01 - CLO25-101: Cost-Effectiveness of Dose Reduction of Antibody-Drug Conjugates for Breast Cancer.Gabrielle Librizzi, Jules Cohen
Journal of the National Comprehensive Cancer Network. 2025-03-28
Press Mentions
Breast Cancer Rate Growing Among Women Under Age 50October 9th, 2025- Greenwich LifeSciences Provides Year End UpdateDecember 29th, 2022
- 7 Ways to Lower Your Breast Cancer RiskOctober 4th, 2022
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHealthfirst New York
HIP of New York - Select PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
